Helen Goodridge, PhD, is an immunologist whose research focuses on neutrophils, macrophages and dendritic cells, which are key players in innate immunity and inflammation. The Goodridge lab is characterizing the mechanisms that regulate the production of these cells (myelopoiesis), the signals that instruct their responses to microbial components and other "danger signals," and the roles of these cells in antimicrobial immunity, inflammatory disease, neurodegenerative disease, cancer and aging.

• Undergraduate: University of Cambridge, 1997
• Doctorate: University of Glasgow, 2001

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Biomedical Sciences
• Cancer
• Medicine
• Regenerative Medicine Institute (Board of Governors Regenerative Medicine Institute)